Title
OVHIPEC-2
Host/Owner
Cancer Trials Ireland
Location(s)
Mater Hospital (currently)
Eligibility
This trial is open to females aged 18 years or older who have a formal diagnosis from their doctor of epithelial ovarian, fallopian tube, or extra-ovarian cancer. Epithelial ovarian cancer is a type of cancer that originates in the cells covering the surface of the ovaries. In Stage III, the cancer typically extends beyond the ovaries and may involve the pelvic organs, such as the fallopian tubes or the lining of the abdominal cavity. It may also involve nearby lymph nodes.
Inclusion Criteria:
- candidate for primary CRS
- histological or cytological proven FIGO stage III primary epithelial ovarian, fallopian tube, or extra-ovarian cancer
Exclusion Criteria:
- history of previous malignancies within 5 years prior to inclusion
- FIGO stage IV disease
- complete primary cytoreduction is impossible
- prior treatment for the current malignancy
Open & close dates
Opened in Ireland August 2022.
Expected Last Patient enrolled December 2024.
Who to contact
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
